Search clinical trials for: Imiquimod Vehicle

Total 1824 results

Taro Pharmaceuticals USA

Completed

Bioequivalence Study of Two Imiquimod Cream 5%

Actinic Keratosis

United States
Graceway Pharmaceuticals, LLC

Completed

Cellular and Molecular Events During Treatment of Actinic Keratosis With Imiquimod 5% Cream

Actinic Keratosis

United States
MEDA Pharma GmbH & Co. KG

Completed

Evaluation of Two Different Non-invasive Techniques to Monitor the Clearance of Actinic Keratosis Lesions

Actinic Keratosis

France
Actavis Mid-Atlantic LLC

Completed

A Bioequivalence Study With Clinical Endpoints Comparing Generic Imiquimod Cream, 3.75% and Zyclara™ (Imiquimod) Cream, 3.75% in Subjects With Actinic Keratoses

Actinic Keratoses

United States
Teva Pharmaceuticals USA

Completed

Study Comparing Imiquimod Cream, 3.75% to Zyclara® (Imiquimod) Cream, 3.75% in the Treatment of Actinic Keratosis

Actinic Keratosis

United States
Actavis Inc.

Completed

Bioequivalence of Generic Imiquimod Cream, 5% When Compared to Aldara™ (Imiquimod) Cream, 5% in the Treatment of Actinic Keratosis

Actinic Keratoses

United States
Taro Pharmaceuticals USA

Completed

Clinical Study to Evaluate the Bioequivalence of Two Imiquimod Cream 3.75% Formulations in Patients With Actinic Keratosis.

Actinic Keratosis
Apotex Inc.

Completed

A Randomized, Double-Blind, Parallel-Group, Vehicle-Controlled Therapeutic Equivalence Study of Three Imiquimod Cream 5% Treatments for Patients With Actinic Keratosis

Actinic Keratosis
VA Office of Research and Development

Not yet recruiting

Basal Cell Carcinoma Chemoprevention Trial (B3C)

Basal Cell Carcinoma

United States
Hospital de Clinicas de Porto Alegre
Federal University of Rio Grande do Sul

Terminated

Topical Application of Imiquimod Gel at Different Concentrations in Actinic Cheilitis

Actinic Cheilitis

Brazil
MEDA Pharma GmbH & Co. KG

Completed

Study of Imiquimod Cream Prior to Ablative Therapy in External Ano-Genital Warts

Genital Warts

Italy
Graceway Pharmaceuticals, LLC

Completed

Phase 3 Study of Imiquimod Creams in the Treatment of External Genital Warts

Genital Warts

United States
Actavis Inc.

Completed

A Study to Evaluate the Safety and Efficacy Imiquimod Cream, 2.5% in Participants With Actinic Keratoses

Actinic Keratosis

United States
Graceway Pharmaceuticals, LLC

Completed

Safety and Effectiveness Study of Imiquimod Creams in the Treatment of External Genital Warts

Genital Warts

United States
Graceway Pharmaceuticals, LLC

Completed

Open-Label Safety Study to Evaluate Imiquimod Cream, 5% for Large Areas of Actinic Keratosis

Keratosis

United States
The University of Hong Kong

Completed

ID HBV Vaccination With Imiquimod in OBI

Hepatitis B

Hong Kong
Graceway Pharmaceuticals, LLC

Completed

Open-label Study to Evaluate Clearance of Superficial Basal Cell Carcinoma After Use of Imiquimod 5% Cream

Superficial Basal Cell Carcinoma

Australia, New Zealand
Intravacc B.V.
Novotech (Australia) Pty Limited

Completed

Safety and Efficacy of Intranasal Administration of Avacc 10 Vaccine Against COVID-19 in Healthy Volunteers (ITV2002)

COVID-19

Australia
Maruho Co., Ltd.

Completed

Topical Challenge With Omiganan and Imiquimod in Healthy Volunteers

Healthy

Netherlands
MEDA Pharma GmbH & Co. KG

Completed

A Study to Evaluate Effectiveness of Imiquimod 5% Cream in Superficial Basal Cell Carcinoma

Basal Cell Carcinoma

Germany
University of British Columbia
Vancouver Coastal Health Research Institute; 3M

Completed

Safety and Efficacy of Imiquimod Applied in Dose-Cycle for Actinic Keratoses

Actinic Keratoses

Canada
MEDA Pharma GmbH & Co. KG

Completed

A Study to Evaluate the Effectiveness and Safety of Multiple Applications of Imiquimod 5% Cream for the Treatment of Actinic Keratoses in Organ Transplant Recipients

Actinic Keratosis
Wake Forest University

Completed

Treatment of Nodular Basal Cell Carcinoma (BCC) With Imiquimod 5% Cream After Curettage

Basal Cell Carcinoma

United States
MEDA Pharma GmbH & Co. KG
ORION Sante

Completed

Imiquimod 5% Cream in the Treatment of External Genital or Perianal Warts in HIV+ Patients

Warts

Belgium, France
Massachusetts General Hospital

Completed

Topical Imiquimod 5% Cream for Treatment of Cutaneous Neurofibromas in Adults With Neurofibromatosis 1

Neurofibromatosis Type 1 | Cutaneous Neurofibromas

United States
The Hospital for Sick Children

Completed

Imiquimod in Children With Plaque Morphea

Scleroderma, Localized

Canada
Graceway Pharmaceuticals, LLC

Completed

Safety and Effectiveness Study of Imiquimod Creams for Treatment of Actinic Keratoses (AKs)

Actinic Keratoses

United States
Graceway Pharmaceuticals, LLC

Completed

1-Year Follow up to the 1473-IMIQ Study

Keratosis

United States
Icahn School of Medicine at Mount Sinai
Bausch Health Americas, Inc.

Completed

Genomic Markers Before and After Treatment of Actinic Keratosis With Imiquimod 3.75% Cream

Actinic Keratosis

United States
United States Naval Medical Center, San Diego

Withdrawn

Anal Dysplasia Study of Men Who Have Sex With Men Living With HIV

HIV | Human Papilloma Virus | Anal Dysplasia

United States
Moberg Pharma AB

Completed

Efficacy and Safety of a New Topical Formulation With Imiquimod (Limtop) Applied 1, 3 or 7 Times Weekly During 2 x 2 Weeks Treatment for Actinic Keratosis on the Head

Actinic Keratosis

Germany
National Naval Medical Center

Completed

Imiquimod Cream in Treating Patients With Basal Cell Skin Cancer

Non-melanomatous Skin Cancer

United States
Medical University of Graz

Completed

Earliest Stage Treatment of Aktinic Keratosis With Imiquimod 3.75% Cream

Actinic Keratoses

Austria
Novartis Pharmaceuticals

Completed

Efficacy and Tolerability of Topical LFX453 for External Genital Warts

External Genital Warts

United States
University of Pennsylvania

Terminated

Imiquimod for Preventing Keloid Recurrence

Keloid

United States
Medical University of Vienna

Completed

ITIC (Imiquimod Therapy in Cervical Intraepithelial Neoplasia)-Trial (ITIC)

Cervical Intraepithelial Neoplasia

Austria
Graceway Pharmaceuticals, LLC

Completed

Study to Assess the Safety and Efficacy of Imiquimod 5% Cream for the Treatment of Actinic Keratosis on the Arms and Hands

Keratosis

United States
Cytos Biotechnology AG

Completed

Safety and Immunogenicity of CYT004-MelQbG10 Vaccine With and Without Adjuvant in Advanced Stage Melanoma Patients

Malignant Melanoma

Switzerland
University of Alberta
3M

Withdrawn

Imiquimod 5% Cream in Plaque-type Morphea: A Pilot, Prospective Open-label Study

Morphea

Canada
Graceway Pharmaceuticals, LLC

Completed

Safety and Effectiveness Study of Actinic Keratosis Treatment Following Cryosurgery

Actinic Keratosis

United States, Canada
The University of Hong Kong

Not yet recruiting

Influenza Vaccine With Topical Imiquimod in Influenza Vaccine Non-responsive Children

Influenza
Queen's Medical Center

Completed

Topical Imiquimod Compared With Surgery in Treating Patients With Basal Cell Skin Cancer

Non-melanomatous Skin Cancer

United Kingdom
Graceway Pharmaceuticals, LLC

Completed

A Study to Evaluate the Effectiveness of Imiquimod 5% Cream for Basal Cell Carcinoma Recurrence

Basal Cell Carcinoma

United States
Graceway Pharmaceuticals, LLC

Completed

Safety and Effectiveness Study of Imiquimod Creams for the Treatment of Actinic Keratoses (AKs)

Actinic Keratosis

United States
St. Justine's Hospital
Graceway Pharmaceuticals, LLC

Completed

A Phase II Study of Imiquimod 5 % Cream for the Treatment of Hemangioma in Infancy

Hemangioma, Capillary

Canada
Medical University of Vienna
Medical University of Graz; Medical University Innsbruck; Krankenhaus Barmherzige... and other collaborators

Terminated

Topical Imiquimod Versus Conization to Treat Cervical Intraepithelial Neoplasia (ITIC2)

Cervical Intraepithelial Neoplasia

Austria
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI); Ohio State University

Completed

Topical Imiquimod in Treating Patients With Recurrent Paget's Disease of the Vulva

Vulvar Cancer

United States
Medicis Global Service Corporation

Unknown

Potential Effect of Topical Imiquimod on Atrial Ectopy in Patients With Actinic Keratosis

Actinic Keratosis

United States
University of Sao Paulo

Unknown

Imiquimod 5% Cream for the Treatment of Periocular Basal Cell Carcinoma (Imiquimod)

Carcinoma, Basal Cell

Brazil
Nantes University Hospital
MEDA Pharma GmbH & Co. KG

Completed

Relevance of Imiquimod as Neo-adjuvant Treatment to Reduce Excision Size and the Risk of Intralesional Excision in Lentigo Malignant of the Face (ImiReduc)

Lentigo Maligna Melanoma (Head or Neck)

France

3

Subscribe